Description générale
INN
Salbutamol
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté en 2003
(TRS
920)
pour
Chronic obstructive pulmonary disease
Wikipédia
DrugBank
Recommandations
Section
Antiasthmatic and medicines for chronic obstructive pulmonary disease
- Parenteral > General injections > IV: 500 µg per mL in 1 mL ampoule (as sulfate); 500 µg per mL in 5 mL ampoule (as sulfate)
- Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate); 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers
Indications